Bank of America’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,886
| Closed | – | – | 7214 |
|
|
2025
Q4 | $0 | Hold |
5,886
| – | – | ﹤0.01% | 8556 |
|
|
2025
Q3 | $0 | Hold |
5,886
| – | – | ﹤0.01% | 8811 |
|
|
2025
Q2 | $0 | Buy |
+5,886
| New | – | ﹤0.01% | 8812 |
|
|
2024
Q3 | – | Sell |
-5,526
| Closed | – | – | 8608 |
|
|
2024
Q2 | $0 | Buy |
5,526
+5,000
| +951% | – | ﹤0.01% | 8604 |
|
|
2024
Q1 | $0 | Buy |
+526
| New | – | ﹤0.01% | 8432 |
|
|
2023
Q4 | – | Sell |
-426
| Closed | – | – | 8454 |
|
|
2023
Q3 | $0 | Hold |
426
| – | – | ﹤0.01% | 8186 |
|
|
2023
Q2 | $0 | Buy |
+426
| New | – | ﹤0.01% | 8226 |
|
|
2022
Q4 | – | Sell |
-427
| Closed | – | – | 8818 |
|
|
2022
Q3 | $0 | Buy |
427
+320
| +299% | – | ﹤0.01% | 8629 |
|
|
2022
Q2 | $0 | Buy |
+107
| New | – | ﹤0.01% | 8855 |
|
|
2022
Q1 | – | Sell |
-126
| Closed | – | – | 9200 |
|
|
2021
Q4 | $0 | Hold |
126
| – | – | ﹤0.01% | 9098 |
|
|
2021
Q3 | $0 | Buy |
126
+20
| +19% | – | ﹤0.01% | 8727 |
|
|
2021
Q2 | $0 | Hold |
106
| – | – | ﹤0.01% | 8477 |
|
|
2021
Q1 | $0 | Hold |
106
| – | – | ﹤0.01% | 8099 |
|
|
2020
Q4 | $0 | Hold |
106
| – | – | ﹤0.01% | 7642 |
|
|
2020
Q3 | $0 | Hold |
106
| – | – | ﹤0.01% | 7457 |
|
|
2020
Q2 | $0 | Hold |
106
| – | – | ﹤0.01% | 7423 |
|
|
2020
Q1 | $0 | Buy |
106
+12
| +13% | – | ﹤0.01% | 7628 |
|
|
2019
Q4 | $0 | Hold |
94
| – | – | ﹤0.01% | 7771 |
|
|
2019
Q3 | $0 | Hold |
94
| – | – | ﹤0.01% | 7798 |
|
|
2019
Q2 | $0 | Hold |
94
| – | – | ﹤0.01% | 7697 |
|
|
2019
Q1 | $1K | Sell |
94
-1,578
| -94% | -$10.4K | ﹤0.01% | 7045 |
|
|
2018
Q4 | $12K | Buy |
1,672
+1,578
| +1,679% | +$11.5K | ﹤0.01% | 6611 |
|
|
2018
Q3 | $1K | Buy |
+94
| New | +$678 | ﹤0.01% | 7221 |
|
|
2017
Q2 | – | Sell |
-2,500
| Closed | -$14K | – | 7487 |
|
|
2017
Q1 | $14K | Buy |
2,500
+1,989
| +389% | +$11.5K | ﹤0.01% | 6455 |
|
|
2016
Q4 | $3K | Buy |
+511
| New | +$3.07K | ﹤0.01% | 6824 |
|
|
2016
Q1 | – | Sell |
-249
| Closed | -$1K | – | 7821 |
|
|
2015
Q4 | $1K | Buy |
+249
| New | +$1.34K | ﹤0.01% | 7267 |
|
|
2015
Q3 | – | Sell |
-247
| Closed | -$1K | – | 7824 |
|
|
2015
Q2 | $1K | Buy |
+247
| New | +$1.3K | ﹤0.01% | 7223 |
|
|
2015
Q1 | – | Sell |
-521
| Closed | -$3K | – | 8207 |
|
|
2014
Q4 | $3K | Sell |
521
-9,780
| -95% | -$49.9K | ﹤0.01% | 7460 |
|
|
2014
Q3 | $50K | Buy |
10,301
+14
| +0.1% | +$75 | ﹤0.01% | 6515 |
|
|
2014
Q2 | $58K | Buy |
10,287
+8,266
| +409% | +$50.2K | ﹤0.01% | 6557 |
|
|
2014
Q1 | $15K | Sell |
2,021
-5,734
| -74% | -$38K | ﹤0.01% | 7059 |
|
|
2013
Q4 | $47K | Buy |
7,755
+6,352
| +453% | +$38.3K | ﹤0.01% | 6604 |
|
|
2013
Q3 | $8K | Sell |
1,403
-4,096
| -74% | -$19.6K | ﹤0.01% | 7271 |
|
|
2013
Q2 | $22K | Buy |
+5,499
| New | +$20.5K | ﹤0.01% | 6933 |
|
Other funds holding SVA
O
VC
NAH
HI
HI
Bank of America's SVA Position: Q1 2026 in Review
Bank of America sold out of Sinovac Biotech, Ltd (SVA) in Q1 2026, closing a stake of 5,886 shares.
Bank of America first reported a position in SVA in Q2 2013 and held it in 34 quarters. The position peaked at $58K in Q2 2014. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.
- Bank of America reported no remaining Sinovac Biotech, Ltd position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 5,886 Sinovac Biotech, Ltd shares in Q1 2026.
- Bank of America first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 34 quarters.
- Bank of America's Sinovac Biotech, Ltd position peaked at $58K in Q2 2014.
- 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.